Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-06-03
1993-05-04
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 77, 514 78, 514109, 514114, 548119, 558169, A61K 3166, A61K 31675, C07F 902, C07F 928
Patent
active
052082237
ABSTRACT:
Phospocholine derivatives having the formula: ##STR1## in which W, Z, Q and R are described in the specification are disclosed as useful for inhibiting the enzyme phospholipase A.sub.2. Methods of making and using the compounds are also disclosed.
REFERENCES:
patent: 4640913 (1987-02-01), Wissner
patent: 4697031 (1987-09-01), Wissner
patent: 4699990 (1987-10-01), Wissner
patent: 4703130 (1987-10-01), Wissner
patent: 4762942 (1988-08-01), Wissner
patent: 4883816 (1989-11-01), Wissner
patent: 4894367 (1990-01-01), Wissner
patent: 4900731 (1990-02-01), Wissner et al.
patent: 4933365 (1990-06-01), Marshall
patent: 4939127 (1990-07-01), Wissner
patent: 4959357 (1990-09-01), Reers
patent: 4962096 (1990-10-01), Masaki
patent: 5144045 (1992-09-01), Wissner et al.
Flower, Biochem, Pharmac., 25, 285 (1976).
Lapetina, Annu. Rep. Med. Chem., 19, 213 (1984).
Dennis, The Enzymes, Academic Press, vol., 16, Chapter 9 (1983).
Wilkenson, AntiInflammatory Phospholipase A.sub.2 Inhibitor Drugs to the Future, vol. 15, No. 2, p. 139-148 (1990).
Green Kenneth E.
Hamann Philip R.
Schaub Robert E.
Wissner Allan
American Cyanamid Company
Szatkowski Thomas S.
Tsang Cecilia
LandOfFree
Phosphocholine derivative inhibitors of phospholipase A.sub.2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphocholine derivative inhibitors of phospholipase A.sub.2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphocholine derivative inhibitors of phospholipase A.sub.2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1975278